LGND Ligand Pharmaceuticals Incorporated

NASDAQ
$286.85

Ligand Pharmaceuticals Incorporated (LGND) Earnings News

Earnings press releases, previews and reviews for Ligand Pharmaceuticals Incorporated (LGND), newest first. Our most recent is review: Ligand's Royalty Engine Drives a Clean EPS Beat and Second Guidance Raise, but Held Revenue Outlook and a Heavier Balance Sheet Temper the Story.